Novartis AG Share Price EURONEXT - EURONEXT LONDON
Stocks
US66987V1098
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Cboe BZX
05:15:28 08/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 142.27 USD | 0.00% |
|
0.00% | - |
| 03:34pm | Argenx Shares Plunge After Autoimmune-Disease Trial Halt | DJ |
| 02:53pm | Fresenius Medical Care replaces CEO, stock under pressure | DP |
| Market Cap | 27TCr 24TCr 23TCr 21TCr 39TCr 26,47200Cr 39TCr 2,74100Cr 1,07100Cr 13,46300Cr 1,02700Cr 1,00500Cr 43,28000Cr | P/E 2026 * |
20.3x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 31TCr 27TCr 25TCr 23TCr 44TCr 29,51900Cr 44TCr 3,05700Cr 1,19400Cr 15,01200Cr 1,14600Cr 1,12100Cr 48,26100Cr | EV / Sales 2026 * |
5.28x | EV / Sales 2027 * | 4.91x |
| Free-Float |
91.66% | Yield 2026 * |
3.01% | Yield 2027 * | 3.14% |
Last Transcript: Novartis AG
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 27TCr | |
| +2.70% | +2.73% | +40.91% | +110.31% | 1,06000Cr | |
| +1.44% | -2.38% | +36.83% | +63.95% | 62TCr | |
| +1.75% | +3.73% | +16.55% | +83.05% | 48TCr | |
| +0.60% | -1.73% | +62.98% | +37.46% | 35TCr | |
| -1.51% | +1.60% | +21.73% | +41.36% | 35TCr | |
| -1.15% | +0.51% | +11.42% | +34.64% | 27TCr | |
| -1.03% | -1.86% | -5.70% | +11.02% | 25TCr | |
| +2.60% | -2.00% | +39.77% | +54.44% | 22TCr | |
| +1.82% | -1.48% | +25.75% | +96.48% | 18TCr | |
| Average | -0.50% | -0.48% | +27.80% | +59.19% | 42.09TCr | |
| Weighted average by Cap. | -0.42% | +0.04% | +31.46% | +70.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.78TCr 5.16TCr 4.82TCr 4.38TCr 8.24TCr 5,59000Cr 8.3TCr 58TCr 23TCr 2,84300Cr 22TCr 21TCr 9,13900Cr | 6.15TCr 5.49TCr 5.13TCr 4.66TCr 8.77TCr 5,94800Cr 8.83TCr 62TCr 24TCr 3,02500Cr 23TCr 23TCr 9,72500Cr |
| Net income | 1.45TCr 1.29TCr 1.21TCr 1.1TCr 2.06TCr 1,40000Cr 2.08TCr 14TCr 5.66TCr 71TCr 5.43TCr 5.32TCr 2,28900Cr | 1.61TCr 1.44TCr 1.34TCr 1.22TCr 2.3TCr 1,55700Cr 2.31TCr 16TCr 6.3TCr 79TCr 6.04TCr 5.91TCr 2,54600Cr |
| Net Debt | 3.15TCr 2.81TCr 2.63TCr 2.38TCr 4.49TCr 3,04600Cr 4.52TCr 32TCr 12TCr 1,54900Cr 12TCr 12TCr 4,98100Cr | 2.83TCr 2.53TCr 2.36TCr 2.14TCr 4.03TCr 2,73700Cr 4.06TCr 28TCr 11TCr 1,39200Cr 11TCr 10TCr 4,47400Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
Select your edition
All financial news and data tailored to specific country editions
